Request live demo now: Request a free demo Speak to Sales Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC It first revealed plans to carve out different . This is Warburg Pincus' 214th transaction in the United States. Informa will retain a 15 per cent stake in the company. Informa earlier this month announced that it has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division, to Warburg Pincus for 1.9bn, while separately commencing a share buyback. (Reuters) -Informa agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the British events organiser announced on Thursday, sending shares rising by 7%. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence,. UAE UNITED STATES INVESTMENT M&A. The value created in this high-quality business and its significant future growth potential have led to a binding agreement with Warburg Pincus that values Pharma Intelligence at 1.9bn, equating to an attractive EV/EBITDA multiple based on 2020 reported figures or 2021 expected outcomes. View job details, responsibilities & qualifications. London-listed events organiser Informa PLC has agreed to sell its pharma intelligence business to Warburg Pincus for 1.9 billion, according to a statement today. Adds details on divestment, shares, trading update Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New. london/new york, june 1 2022 - pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that warburg pincus, a leading global growth investor, has completed its acquisition of the business from informa plc (lse:inf.l), the international Warburg Pincus LLC has tapped the private credit market to fund its 1.7 billion pound ($2.3 billion) takeover of Informa Plc's Pharma Intelligence division. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory . Leading global growth investor Warburg Pincus and Abu Dhabi sovereign fund Mubadala Investment Company have completed the acquisition of Informa's Pharma Intelligence, a provider of specialist data, software for clinical trials, drug development, and regulatory compliance. london and new york, june 01, 2022 (globe newswire) -- pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory. Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials . Pharma Intelligence has also announced the appointment of Jay Nadler as executive chair, effective immediately. LONDON, Feb. 10, 2022 /CNW/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider . Skipta communities are aligned by specialty or disease state so you get the most relevant message to your target . The Abu Dhabi-based Mubadala Investment Company has joined Warburg Pincus in the 1.9bn investment, while Informa retains a 15% equity interest in the business. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading. Informa, the global publishing, business intelligence and events company, announced late last week that it's selling its pharma intelligence unit to the private-equity firm Warburg Pincus for about $2.5 billion. london and new york, june 01, 2022 (globe newswire) pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that warburg pincus, a leading global growth investor, has completed its acquisition of the business from informa plc (lse:inf.l), Informa will continue to own 15% of the asset. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B Markets . Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa, the international B2B markets knowledge services and business intelligence group. Mubadala Investment Company, the Abu Dhabi . london and new york, june 01, 2022 (globe newswire) -- pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Adds details on divestment, shares, trading update Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets our customers come from over 3000 of the world's leading pharmaceutical, contract research organizations (CROs), medical technology, biotechnology and healthcare service providers, including the top 10 global pharma and . Warburg Pincus has completed its acquisition of Informa's Pharma Intelligence business and is now looking to extend the unit's leading position in the $22bn pharmaceutical data and analytics market. We know who they are and how they engage with information. . An American private equity firm has agreed to buy Informa's pharmaceuticals data business in a deal valuing the unit at . 10 February 2022. Global private equity firm Warburg Pincus and Abu Dhabi sovereign wealth fund Mubadala Investment Company have bought Informa's Pharma Intelligence division for GBP 1.9bn, an entry multiple of 20-25x. The Abu Dhabi-based Mubadala Investment Company has joined Warburg Pincus in the 1.9bn ($2.4bn) investment, while Informa retains a 15% equity interest in the business. June 6, 2022. Events organiser and publisher Informa has agreed to sell 85 per cent of its pharma intelligence business to New York-based investment fund Warburg Pincus. Informa, the global publishing, business intelligence and events company, announced late last week that it's selling its pharma intelligence unit to the private-equity firm Warburg Pincus for . Pharma Intelligence is a provider of specialist intelligence and data for Clinical Trials, Drug Development and Regulatory . LONDON, Feb. 10, 2022 /CNW/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and. Informa announced that it would be. Informa Intelligence Senior Business Analyst jobs in New York, NY. Warburg Pincus is buying the company's data division for 1.9 billion. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of . LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B . london, february 10, 2022 warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and. Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC, the international B2B markets knowledge services and business intelligence group. Warburg Pincus. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a Sunday, 16 October 2022 08:00 GMT Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the events. The deal comes after Informa said it would divest its portfolio of intelligence businesses, of which the pharma segment is the largest at about 40% of total divisional revenue of . Stephen A. Carter: "We are delighted to partner with Warburg Pincus and share their view on its future growth potential." GuruFocus Article or News written by PRNewswire and the topic is about: Media Contacts Pharma Intelligence Blair Dawson | Vice President, Commercial Development & Launch 919-413-4616 / blair.dawson@informa.com. Pharma Intelligence has also announced the appointment of Jay Nadler as executive chair, effective immediately. Publisher's Spotlight: Leading global growth investor Warburg Pincus has acquired Informa's Pharma Intelligence unit, the publisher of HBW Insight. Informa, the international B2B markets, knowledge services and business intelligence group has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division, to Warburg Pincus for 1.9bn, while separately commencing a share buyback. Informa sells Pharma Intelligence to Warburg Pincus for 1.9bn Disposal comes two months after UK company first announced plan to offload intelligence unit Informa's new strategy shifts its. This is Warburg Pincus' 17th transaction in New York. 919-413-4616 / blair.dawson@informa.com Warburg Pincus Jenna Ward | Europe Communications Director +44 7570844338 / jenna.ward@warburgpincus.com Next steps Request a Demo Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage. and regulatory compliance, from Informa PLC, the international B2B markets knowledge . The pharma unit is part of the company's larger intelligence division, which Informa said in December it would. Founded in 1966, Warburg Pincus has raised 21 private equity and two real estate funds, which have invested more than $103 billion in over 1,025 companies in more than 40 countries. Rachel Lewis and Amy-Jo Crowley. The world's largest exhibition group had made plans in December to divest the entire intelligence unit, which houses brands such as maritime data provider . 10 Feb, 2022, 13:51 IST. Informa Plc agreed to sell 85% of its Pharma Intelligence division to private equity firm Warburg Pincus LLC for 1.7 billion pounds ($2.3 billion), in a key part of the events and data. Skipta is where your healthcare target is right now 1 network 25 communities 700,000+ verified members You know the type of healthcare professionals you need to reach. In 2020, this business accounted for approximately 40% of Informa Intelligence reported divisional revenues of 305 million. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data . Skipta | 2,121 LinkedIn. Informa Plc agreed to sell 85% of its Pharma Intelligence division to private equity firm Warburg Pincus LLC for 1.7 billion pounds ($2.3 billion), in a key part of the events and data company's plan growth plan after the pandemic. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence Mubadala Investment Company, the Abu Dhabi based . 2 Informa PLC | Informa to divest Pharma Intelligence for 1.9bn and commence share buyback informa.com Under today's agreement, Warburg Pincus' commitment to future investment and growth, and our own knowledge and belief in the business, has led to a structure whereby 85% of equity value is realised today, london, feb. 10, 2022 /cnw/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets knowledge services Informa has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division, to Warburg Pincus for 1.9 billion, while separately commencing a share buyback. Citeline, formerly Informa Pharma Intelligence - a leading provider of specialist intelligence, data and software for clinical trials, drug development, and regulatory compliance - was recently acquired by Warburg Pincus from Informa Inc. for 1.9bn ($2.4bn). Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence,. Warburg Pincus Jenna Ward | Europe Communications . Informa has agreed to sell Pharma Intelligence to US private equity group Warburg Pincus for 1.9bn, as the UK firm looks to boost shareholder value. The merger is expected to close in the second half of 2022. Target Pharma Intelligence On February 10, 2022, private equity firm Warburg Pincus acquired software company Pharma Intelligence from Informa Acquisition Highlights This is Warburg Pincus' 30th transaction in the Software sector. --Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, . Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. london, february 10, 2022 -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets knowledge services Feb 10, 2022, 03:18 ET. The investors plan to extend the company's position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence,. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory . london, february 10, 2022 warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets knowledge services and Warburg Pincus has completed its acquisition of Informa's Pharma Intelligence business and is now looking to extend the unit's leading position in the $22bn pharmaceutical data and analytics market. LONDON, Feb. 10, 2022 /PRNewswire/ Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Publisher's Spotlight: Leading global growth investor Warburg Pincus has acquired Informa's Pharma Intelligence unit, the publisher of Medtech Insight.
Eurostat Structural Business Statistics, Stax Payments Pricing, Magnitude Of Magnetic Field, Percentage Yield Experiment, Marine Science Scholarships 2022, Herbs To Increase Endometrial Thickness, Europa-park Opening Hours, Flight Path Western Plaguelands, Elements Of Climate In Geography,